Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease

Leen Wehbeh, Sama Alreddawi, Roberto Salvatori

Research output: Contribution to journalReview article

Abstract

Introduction: Hypophysitis is a rare disorder, defined as inflammation of the pituitary gland that may result in pituitary enlargement and varying anterior and posterior pituitary hormonal deficits. It involves different histopathological subtypes and variable etiologies, with considerable overlap between classification systems. Histopathology is the gold standard diagnostic approach. Areas covered: In this article, we will review the major histopathological subtypes of hypophysitis with a special focus on immunoglobulin G4 (IgG4)-related hypophysitis and immune checkpoint inhibitor-induced hypophysitis, given their recent appearance and increasing incidence. We will summarize the similarities and differences between the different subtypes as it relates to epidemiology, pathogenesis, presentation, diagnosis, and management. Expert opinion: Hypophysitis is a heterogeneous and wide term used to describe different, possibly distinct diseases often with poorly understood pathogenesis. It involves a wide range of subtypes with certain differences in incidence rates, pathogenesis, and management. Management usually focuses on relieving the mass effect symptoms and replacing the deficient pituitary hormones. Spontaneous recovery is possible but recurrence is not uncommon.

Original languageEnglish (US)
Pages (from-to)167-178
Number of pages12
JournalExpert Review of Endocrinology and Metabolism
Volume14
Issue number3
DOIs
StatePublished - May 4 2019

Fingerprint

Immunoglobulins
Pituitary Hormones
Incidence
Expert Testimony
Pituitary Gland
Epidemiology
Hypophysitis
Inflammation
Recurrence

Keywords

  • Autoimmune
  • CTLA-4
  • granulomatous
  • hypophysitis
  • IgG4
  • immune checkpoint inhibitors
  • immunoglobulin G4
  • lymphocytic
  • xanthomatous

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease. / Wehbeh, Leen; Alreddawi, Sama; Salvatori, Roberto.

In: Expert Review of Endocrinology and Metabolism, Vol. 14, No. 3, 04.05.2019, p. 167-178.

Research output: Contribution to journalReview article

@article{21db96e921e04b62a43795cc68140a75,
title = "Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease",
abstract = "Introduction: Hypophysitis is a rare disorder, defined as inflammation of the pituitary gland that may result in pituitary enlargement and varying anterior and posterior pituitary hormonal deficits. It involves different histopathological subtypes and variable etiologies, with considerable overlap between classification systems. Histopathology is the gold standard diagnostic approach. Areas covered: In this article, we will review the major histopathological subtypes of hypophysitis with a special focus on immunoglobulin G4 (IgG4)-related hypophysitis and immune checkpoint inhibitor-induced hypophysitis, given their recent appearance and increasing incidence. We will summarize the similarities and differences between the different subtypes as it relates to epidemiology, pathogenesis, presentation, diagnosis, and management. Expert opinion: Hypophysitis is a heterogeneous and wide term used to describe different, possibly distinct diseases often with poorly understood pathogenesis. It involves a wide range of subtypes with certain differences in incidence rates, pathogenesis, and management. Management usually focuses on relieving the mass effect symptoms and replacing the deficient pituitary hormones. Spontaneous recovery is possible but recurrence is not uncommon.",
keywords = "Autoimmune, CTLA-4, granulomatous, hypophysitis, IgG4, immune checkpoint inhibitors, immunoglobulin G4, lymphocytic, xanthomatous",
author = "Leen Wehbeh and Sama Alreddawi and Roberto Salvatori",
year = "2019",
month = "5",
day = "4",
doi = "10.1080/17446651.2019.1598260",
language = "English (US)",
volume = "14",
pages = "167--178",
journal = "Expert Review of Endocrinology and Metabolism",
issn = "1744-6651",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease

AU - Wehbeh, Leen

AU - Alreddawi, Sama

AU - Salvatori, Roberto

PY - 2019/5/4

Y1 - 2019/5/4

N2 - Introduction: Hypophysitis is a rare disorder, defined as inflammation of the pituitary gland that may result in pituitary enlargement and varying anterior and posterior pituitary hormonal deficits. It involves different histopathological subtypes and variable etiologies, with considerable overlap between classification systems. Histopathology is the gold standard diagnostic approach. Areas covered: In this article, we will review the major histopathological subtypes of hypophysitis with a special focus on immunoglobulin G4 (IgG4)-related hypophysitis and immune checkpoint inhibitor-induced hypophysitis, given their recent appearance and increasing incidence. We will summarize the similarities and differences between the different subtypes as it relates to epidemiology, pathogenesis, presentation, diagnosis, and management. Expert opinion: Hypophysitis is a heterogeneous and wide term used to describe different, possibly distinct diseases often with poorly understood pathogenesis. It involves a wide range of subtypes with certain differences in incidence rates, pathogenesis, and management. Management usually focuses on relieving the mass effect symptoms and replacing the deficient pituitary hormones. Spontaneous recovery is possible but recurrence is not uncommon.

AB - Introduction: Hypophysitis is a rare disorder, defined as inflammation of the pituitary gland that may result in pituitary enlargement and varying anterior and posterior pituitary hormonal deficits. It involves different histopathological subtypes and variable etiologies, with considerable overlap between classification systems. Histopathology is the gold standard diagnostic approach. Areas covered: In this article, we will review the major histopathological subtypes of hypophysitis with a special focus on immunoglobulin G4 (IgG4)-related hypophysitis and immune checkpoint inhibitor-induced hypophysitis, given their recent appearance and increasing incidence. We will summarize the similarities and differences between the different subtypes as it relates to epidemiology, pathogenesis, presentation, diagnosis, and management. Expert opinion: Hypophysitis is a heterogeneous and wide term used to describe different, possibly distinct diseases often with poorly understood pathogenesis. It involves a wide range of subtypes with certain differences in incidence rates, pathogenesis, and management. Management usually focuses on relieving the mass effect symptoms and replacing the deficient pituitary hormones. Spontaneous recovery is possible but recurrence is not uncommon.

KW - Autoimmune

KW - CTLA-4

KW - granulomatous

KW - hypophysitis

KW - IgG4

KW - immune checkpoint inhibitors

KW - immunoglobulin G4

KW - lymphocytic

KW - xanthomatous

UR - http://www.scopus.com/inward/record.url?scp=85065758311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065758311&partnerID=8YFLogxK

U2 - 10.1080/17446651.2019.1598260

DO - 10.1080/17446651.2019.1598260

M3 - Review article

C2 - 30939947

AN - SCOPUS:85065758311

VL - 14

SP - 167

EP - 178

JO - Expert Review of Endocrinology and Metabolism

JF - Expert Review of Endocrinology and Metabolism

SN - 1744-6651

IS - 3

ER -